Skip to main content
. 2021 Jan 18;7(1):00191-2020. doi: 10.1183/23120541.00191-2020

TABLE 1.

Clinical characteristics of the patients with Mycobacterium abscessus respiratory isolates

Patients n 371
Age years 67 (55–77)
Men 189 (50.9)
NTM-pulmonary disease 260 (70.1)
 Nodular-bronchiectatic type 137 (36.9)
 Fibro-cavitary type 14 (3.8)
 Mixed or other type 109 (29.3)
Underlying lung diseases 183 (49.3)
 Bronchiectasis 131 (35.3)
 Chronic obstructive pulmonary disease 57 (15.4)
 Remote history of pulmonary tuberculosis 58 (15.6)
 Interstitial lung disease 3 (0.8)
 Pneumoconioses 1 (0.3)
Diabetes mellitus 72 (19.4)
Congestive heart failure 39 (10.5)
Chronic kidney disease stage IV–V 26 (7.0)
Chronic hepatitis B 28 (7.5)
Chronic hepatitis C 11 (3.0)
Autoimmune disease 18 (4.9)
Anti-interferon-γ autoantibodies 9 (2.4)
Anti-GM-CSF autoantibodies 1 (0.3)
Gastro-oesophageal reflux disease 43 (11.6)
Human immunodeficiency virus infection 1 (0.3)
Haematological/bone marrow transplantation 5 (1.3)
Solid organ transplantation 3 (0.8)
Thyroid disease 22 (5.9)
Neurological disease 76 (20.5)
Malignancy 89 (24.0)
 Head and neck cancer 22 (5.9)
 Upper gastrointestinal cancer 16 (4.4)
 Lung cancer 13 (3.5)
 Renal, bladder and prostate cancer 11 (3.0)
 Colorectal cancer 9 (2.4)
 Breast cancer 9 (2.4)
 Haematological 5 (1.3)
 Neuroendocrine 3 (0.8)
 Other 4 (1.1)
Deaths during follow-up 113 (30.5)
 In-hospital deaths 66 (17.8)
 Cause of death: sepsis (including pneumonia) 34 (9.2)
 Cause of death: pneumonia 30 (8.1)
 Cause of death: NTM-PD 5 (1.3)
 Cause of death: cancer 6 (1.6)
 Cause of death: haemorrhage 4 (1.1)
Duration of follow-up years 2.8±8.7

Data are presented as median (interquartile range), n (%) or mean±sd, unless otherwise stated. NTM: nontuberculous mycobacteria; GM-CSF: granulocyte–macrophage colony-stimulating factor.